Skip to main content

Merck results beat expectations on strong Keytruda, Gardasil and Covid drug growth

Merck's revenue and earnings beat expectations, and it hiked its sales forecast while lowering its profit outlook.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.